Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27941-27950 Newer>

The Motley Fool January 5, 2008 Rick Aristotle Munarriz	The Fool's Look Ahead Who's reporting this week: Lawson Software... Apollo Group... Ruby Tuesday... Shuffle Master... Shaw Communications...
The Motley Fool January 5, 2008 Rick Aristotle Munarriz	A Fool Looks Back The week that was on Wall Street: Netflix teams up with South Korea's LG Electronics to deliver flicks directly to their high-def televisions... Overstock founder Jason Lindsey retires... Amazon is upgraded... Starbucks is downgraded...
The Motley Fool January 5, 2008 Adam J. Wiederman	Bear Market Buys How to find the best investments when the market is tough.
The Motley Fool January 4, 2008 Rich Smith	Bed Bath & Beyond the Closing Bell Shares of home furnishings retailer Bed Bath & Beyond fall off a cliff when the company finally reports Q3 earnings.
The Motley Fool January 4, 2008 Toby Shute	A Tale of Two Contracts Two offshore drilling deals make waves this week. Superior Energy Services wins a giant contract to decommission wells for BP; Atwood Oceanics has won a contract to build new semisubmersibles for Chevron.
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool January 4, 2008 Alyce Lomax	Talbots: No Men, Children Allowed Talbots decides to shut down its stores that target men and children. That may be a wise move, but don't expect it to cure everything.
The Motley Fool January 4, 2008 Morgan Housel	Goldman's Double Take Goldman Sachs, one of the largest issuers of mortgage-backed securities over the past two and a half years, made huge amounts of money betting against what were in essence the same products it had been peddling to clients.
The Motley Fool January 4, 2008 Rich Smith	Foolish Forecast: Apollo Is Back in Session In advance of first-quarter earnings, analysts expect for-profit educator Apollo Group's revenue and profits to rise.
The Motley Fool January 4, 2008 Brian Orelli	Rabid Growth at Crucell Crucell signs a marketing agreement with Sanofi-Aventis to market Crucell's rabies treatment; who benefits more?
<Older 27941-27950 Newer> Return to current articles.